US NEWS FEEDS
US WorldMeds LLC has received approval from the U.S. Food and Drug Administration for a drug that helps lessen the impact of opioid withdrawal.
The drug, lofexidine, was approved under priority review, which the FDA grants for medications that would provide significant improvements in the safety or effectiveness of the treatment, diagnosis or prevention of serious conditions.
Louisville-based US WorldMeds says this is the first and only non-opioid treatment for the mitigation of withdrawal symptoms.
Louisville Business News - Local Louisville News | Business First of Louisville
READ MORE >
US WorldMeds gets FDA approval for new drug to treat opioid withdrawal